Drug recall · June 1, 2016
Linezolid Injection recall
Why: Lack of Assurance of Sterility: Due to potential for leaking bags.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Linezolid Injection, 600 mg/300 mL Single use container bags (NDC 0703-9060-31), packaged in 10 x 300 mL Single Use Container bags per Box Pack (NDC 0703-9060-33), Rx only, Manufactured In Hungary By: Teva Pharmaceutical Works Ltd., Hungary, H-2100 Godollo, Tancsics M. ut 82 Hungary; Manufactured For: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454
- Lots / codes
Lot # 2520715, Exp Date: 7/17
- Quantity
- 546 bags
- Company
- Teva North America, Horsham, PA
- Distribution
- Nationwide
- Initiated
- April 27, 2016 · Voluntary: Firm initiated
- Classified
- May 24, 2016
- Reported
- June 1, 2016
- Ended
- February 5, 2018
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Linezolid
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.